You are here

Integrated Biotherapeutics, Inc.

Company Information
Address
4 Research Court, Suite 300
Rockville, MD 20850-3220
United States



Information

DUNS: 601000750

# of Employees: 30


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Whispering Gallery Mode Devices for the Rapid Detection of Pan-Filoviruses

    Amount: $299,939.00

    Project Summary Filoviruses, including the Ebola viruses, Marburg viruses, and Cueva virus, are a class of pathogens with enormous health implications. Filoviruses have been implicated in numerous out ...

    STTRPhase I2020Department of Health and Human Services National Institutes of Health
  2. Mining natively paired macque antibodies for Marburg virus protective antibodies

    Amount: $600,000.00

    Project summary Filoviruses are among the deadliest known human viruses. The family Filoviridae contains two clinically relevant genera; Ebolavirus and Marburgvirus that each consist of multiple virus ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  3. Monoclonal antibodies targeting novel sites of vulnerability in marburg virus glycoprotein

    Amount: $600,000.00

    Filoviruses, consisting of two major virus families including the ebolaviruses and marburgviruses (MARV and RAVV), cause periodic outbreaks of severe viral hemorrhagic fever with mortality rates as hi ...

    STTRPhase I2019Department of Health and Human Services National Institutes of Health
  4. Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis

    Amount: $1,985,295.00

    Project Summary Bacillus anthracis (Ba) is a Gram-positive spore forming bacterium that is listed as an agent of highest concern (Category A) by NIAID and CDC. Ba is easy to grow, and its spores can b ...

    STTRPhase II2019Department of Health and Human Services National Institutes of Health
  5. Development of a Universal Immunotherapeutic for Influenza Viruses

    Amount: $290,038.00

    Project Summary Influenza virusINFVresults in global seasonal and pandemic outbreaks estimated to cause severe illness intomillion people annually resulting in significant morbidity and up todeathsThe ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  6. ISTAb- A novel therapy to target staphylococcal toxins at the site of infections

    Amount: $600,000.00

    Project Summary Many bacterial pathogens secrete exotoxins to modify the host-pathogen interactions in a manner that benefits the bacteria. There are several examples of successful prophylaxis and tre ...

    SBIRPhase I2019Department of Health and Human Services National Institutes of Health
  7. Remodeled glycoprotein for broad protection against ebolaviruses

    Amount: $601,655.00

    Project summary TheEbola virus diseaseEVDoutbreak in West Africacaused by the Zaire Ebola virusEBOVresulted in overcases anddeathsThis has been a sobering reminder of the growing threat of the filovir ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  8. Serotype independent therapeutic vaccine for Streptococcus pneumoniae

    Amount: $438,765.00

    In the era of growing antibiotic resistancelife threatening infections with several bacterial pathogens are cause for major concernApproved vaccines exist only for a handful of bacterial pathogensEven ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  9. Infection Site Targeted Antitoxin Antibody (ISTAb) against Bacillus anthracis

    Amount: $594,931.00

    Project Summary The Gram positive bacterium Bacillus anthracis is a very strong candidate for potential bioweaponizationand believed to have actually been weaponized by the former Soviet UnionAnthrax ...

    STTRPhase I2017Department of Health and Human Services National Institutes of Health
  10. Broadly Protective Bispecific Antibodies for Treatment of Ebola Virus Disease

    Amount: $1,861,259.00

    PROJECT SUMMARY The family of Filoviridae consisting of five ebolaviruses and two marburgviruses are causative agents of severe hemorrhagic fever with human case fatality rates ofTheepidemic of Ebola ...

    STTRPhase II2017Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government